loder
Start Typing

Here, you can select the report, if matching with your text

Europe Clinical Trials Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

Europe Clinical Trials Market - By Phase: Phase I – Safety and dosage testing (small group), Phase II – Efficacy and side effects (medium-sized group), Phase III – Confirmation of effectiveness and monitoring of side effects (large group), Phase IV – Post-marketing surveillance after drug approval: By Study Design: Interventional Trials – Participants receive specific interventions (e.g., drug, procedure), Observational Trials – Outcomes are observed without assigning interventions, Expanded Access Trials – For patients not eligible for clinical trials to access investigational treatments; By Therapeutic Area: Oncology (Cancer), Cardiovascular Diseases, Infectious Diseases (e.g., COVID-19, HIV), Neurological Disorders, Autoimmune/Inflammatory Diseases; By Country: Germany, United Kingdom, France, Spain, Italy, Russia, Rest of Europe

Report Code
CVMI29123859
Published
March 26, 2025
Last Updated
March 26, 2025
Coverage
Healthcare • Healthcare
Buy Report $3600.00 single user Speak To An Analyst
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
—
— vs. prior year
CAGR
—
Forecast window: —
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
—
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

Market Overview:

The European clinical trials market is rapidly evolving, driven by regulatory harmonization under the EU Clinical Trials Regulation (CTR), increased investment in decentralized trials, and growth in research on oncology, rare diseases, and precision medicine. Leading research hubs in Germany, France, the UK, and the Netherlands are complemented by a rise in trial activity in Eastern Europe, which is due to cost efficiency and faster patient recruitment.

 

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

11.6

Covers Phase I–IV across pharma, biotech, and medical device segments

2024

16.5

CAGR 7.3% (2019–2024); accelerated by COVID-era trial digitization

2031

25.8

CAGR 6.5% (2024–2031); sustained by rare disease and oncology expansion

 

Market Drivers

  • EU Clinical Trials Regulation (CTR) facilitates single-portal, cross-border applications.
  • Strong academic research infrastructure and public-private partnerships (IMI, ECRIN)
  • Growth in rare disease and pediatric trials supported by EU orphan incentives
  • Adoption of digital recruitment, eConsent, and remote monitoring tools
  • Increasing presence of global CROs and trial sponsors in CEE countries

 

Market Challenges

  • Varying data privacy laws (GDPR) complicating digital trial design
  • Workforce shortages in clinical research nurses and data managers
  • Cost constraints and delays due to multi-country protocol customization

 

Competitive Landscape

Company

Core Strengths

Recent Developments

ICON plc

Oncology trials, DCT platforms

Expanded European HQ in Amsterdam (2024)

IQVIA

Data-driven trials, tech-enabled monitoring

Launched GDPR-compliant eConsent suite (2025)

Labcorp Drug Dev

Early-phase research, biosample logistics

Added EU-wide biomarker lab in Germany (2024)

PPD (Thermo Fisher)

Global reach, regulatory strategy expertise

Partnered with ECRIN for rare disease trials (2025)

 

Regional Insights

  • Western Europe – High trial density and sponsor activity, especially in oncology
  • Central & Eastern Europe – Cost-efficient recruitment and faster start-up timelines
  • Nordics – Pioneering DCTs and biobank-linked studies
Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • IQVIA
  • ICON plc
  • Parexel International
  • Labcorp Drug Development (Covance)
  • PPD (part of Thermo Fisher Scientific)
  • Syneos Health
  • Charles River Laboratories
  • Medpace
  • WuXi AppTec
  • PRA Health Sciences
  • Clinipace
  • PSI CRO
  • Covance Inc.
  • AstraZeneca
  • Novo Nordisk
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
—
Request A Custom Cut
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.

 

Clinical Trials Market Report

 

  1. 1. Clinical Trials Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Clinical Trials Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Clinical Trials Market Research Report - Preface
    1. 2.1 Clinical Trials Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Phase:
      2. 2.1.2 By Study Design
      3. 2.1.3 By Therapeutic Area
      4. 2.1.4 By Region
  3. 3. Clinical Trials Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Phase:, By Study Design, By Therapeutic Area, By Country
    3. 3.3. Opportunities – By Phase:, By Study Design, By Therapeutic Area, By Country
    4. 3.4. Trends – By Phase:, By Study Design, By Therapeutic Area, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Clinical Trials Market Research Report – DROTs Impact Analysis
    1. 4. Clinical Trials Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Clinical Trials Market, By Phase:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Phase I – Safety and dosage testing (small group),
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Phase II – Efficacy and side effects (medium-sized group)
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Phase III – Confirmation of effectiveness and monitoring of side effects (large group)
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 Phase IV – Post-marketing surveillance after drug approval
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Clinical Trials Market, By Study Design, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Interventional Trials – Participants receive specific interventions (e.g., drug, procedure)
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Observational Trials – Outcomes are observed without assigning interventions
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Expanded Access Trials – For patients not eligible for clinical trials to access investigational treatments
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Clinical Trials Market, By Therapeutic Area, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Oncology (Cancer)
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 Cardiovascular Diseases
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Infectious Diseases (e.g., COVID-19, HIV)
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 7.4 Neurological Disorders
    17. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    21. 7.5 Autoimmune/Inflammatory Diseases
    22. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    23. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    24. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    25. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Clinical Trials Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Europe
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Clinical Trials Market - Opportunity Analysis Index, By Phase:, By Study Design, By Therapeutic Area, and Region, 2024 - 2031
  1. 9. Europe Clinical Trials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Phase: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Phase I – Safety and dosage testing (small group),
      2. 9.1.2 Phase II – Efficacy and side effects (medium-sized group)
      3. 9.1.3 Phase III – Confirmation of effectiveness and monitoring of side effects (large group)
      4. 9.1.4 Phase IV – Post-marketing surveillance after drug approval
      9.2 By Study Design Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Interventional Trials – Participants receive specific interventions (e.g., drug, procedure)
      2. 9.2.2 Observational Trials – Outcomes are observed without assigning interventions
      3. 9.2.3 Expanded Access Trials – For patients not eligible for clinical trials to access investigational treatments
      9.3 By Therapeutic Area Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Oncology (Cancer)
      2. 9.3.2 Cardiovascular Diseases
      3. 9.3.3 Infectious Diseases (e.g., COVID-19, HIV)
      4. 9.3.4 Neurological Disorders
      5. 9.3.5 Autoimmune/Inflammatory Diseases
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 Germany
      2. 9.4.2 United Kingdom
      3. 9.4.3 France
      4. 9.4.4 Spain
      5. 9.4.5 Italy
      6. 9.4.6 Russia
    2. 9.5 Europe Clinical Trials Market – Opportunity Analysis Index, By Phase:, By Study Design, By Therapeutic Area, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 Europe Clinical Trials Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (Germany)
      2. 9.7.2 Company 2 (United Kingdom)
      3. 9.7.3 Company 3 (United Kingdom)
    10. Competition Landscape
    1. 10.1 Strategic Dashboard of Top Market Players
    2. 10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 10.2.1 IQVIA
      2. 10.2.2 ICON plc
      3. 10.2.3 Parexel International
      4. 10.2.4 Labcorp Drug Development
      5. 10.2.5 PPD
      6. 10.2.6 Syneos Health
      7. 10.2.7 Charles River Laboratories
      8. 10.2.8 Medpace
      9. 10.2.9 WuXi AppTec
      10. 10.2.10 PRA Health Sciences
      11. 10.2.11 Clinipace
      12. 10.2.12 PSI CRO
      13. 10.2.13 Covance Inc.
      14. 10.2.14 AstraZeneca
      15. 10.2.15 Novo Nordisk
  1. 11. Data Collection Method and Research Approach
  2. 12. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30116 Dec. 1, 2025
$3600.00 single user
View report →
Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI0112 Dec. 1, 2025
$3600.00 single user
View report →
Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30115 Dec. 1, 2025
$3600.00 single user
View report →
Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30114 Nov. 30, 2025
$3600.00 single user
View report →
Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30113 Nov. 30, 2025
$3600.00 single user
View report →
Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI3011 Nov. 30, 2025
$3600.00 single user
View report →
Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30112 Nov. 30, 2025
$3600.00 single user
View report →
Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI2711 Nov. 27, 2025
$3600.00 single user
View report →
Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI27111 Nov. 27, 2025
$3600.00 single user
View report →
Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI2611 Nov. 26, 2025
$3600.00 single user
View report →
Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI26081 Aug. 26, 2025
$3600.00 single user
View report →
Global Osteo-Odonto-Keratoprosthesis (OOKP) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI1008 Aug. 10, 2025
$3600.00 single user
View report →
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
Buy Report Talk To An Analyst
New chat message received
×

Need help?

Chat with our team in a minute.
We usually reply within a few minutes.